logo.gif (2253 bytes)



Home Page

Welcome

Committees

Sponsors

Advance Program

Posters Sessions:

General
Information

Pre and Post Congress Tours

Registered Accompanying Persons Program

Accommodation

Accommodation and Tour Form

Registration Form

 

ADVANCE PROGRAM - Poster Session

TUESDAY, OCTOBER 3, 2000

08:30 - 10:15 Hall A
PL03: NEW FRONTIERS IN INTERVENTIONAL CARDIOLOGY I: THE CHALLENGE OF RESTENOSIS
 08:30 TREATMENT OF IN-STENT RESTENOSIS - FAILURE OF THE MECHANICAL APPROACH (Invited Lecture)
J.P. Bassand, Besancon, France
 08:45 COMPARISON OF CLINICAL AND ANGIOGRAPHIC RESTENOTIC RATES BETWEEN DIRECT STENTING AND STENTING WITH PREDILATATION. RESULTS FROM THE DISCO TRIA
J.M. de la Torre, J. Zueco, T. Colman, A. Figueroa, J.M. Ruiz-Nodar, L. Martinez Elbal, J.R. Lopez Minguez, V. Mainar, C. Rodriguez, I. Calvo, M. Alonso, R. Melgares, J. Moreu, Santander, Spain
 09:00 MECHANISMS OF STENT THROMBOSIS: ROLE OF ANTIPLATELET STRATEGIES (Invited Lecture)
R.R. Makkar, Los Angeles CA, USA
 09:15 STENT COATING FOR PREVENTION OF INSTENT-RESTENOSIS
S. Windecker, I. Mayer, G. de Pasquale, O. Dirsch, P. de Groot, B. Leskosek, B. Meier, O.M. Hess, Bern, Switzerland
 09:30 STENTS AS A VEHICLE FOR LOCAL DRUG DELIVERY (Invited Lecture)
J. Gunn, Sheffield, UK
 09:45 SUSTAINED CLINICAL BENEFIT TWO YEARS AFTER PERCUTANEOUS MYOCARDIAL LASER REVASCULARIZATION IN PATIENTS WITH END-STAGE CORONARY ARTERY DISEASE (Invited Lecture)
B. Lauer, F. Stahl, S. Bratanow, G. Schuler, Leipzig, Germany
 10:00 C o f f e e B r e a k
S66:  ENDOTHELIAL FUNCTION AND ATHEROSCLEROSIS
Chairpersons: T. Muenzel, Hamburg, Germany
C. Rosendorff, Bronx NY, USA
 08:30 ATHEROSCLEROTIC BURDEN AT FIRST SYMPTOMS OF CORONARY ARTERY DISEASE
E. Cerne, I. Kranjec, Ljubljana, Slovenia
 08:45 VITAMIN C AND DEXAMETHASONE PREVENT RADIATION-INDUCED ENDOTHELIUM-DEPENDENT VASOMOTOR DYSFUNCTION AND DE-ENDOTHELIALIZATION
Y-K. On, S-Y. Kim, I-H. Chae, D-W. Sohn, B-H. Oh, M-M. Lee, Y.B. Park, Seoul, South Korea
 09:00  IS THE PREVENTION OF VASCULAR ENDOTHELIUM DYSFUNCTION A KEY TO SYNDROME X TREATMENT?
G. Latocha, W.J. Musiat, W. Kochman, S. Dobrzycki, K. Kaminski, J. Korecki, Bialystok, Poland
 09:15 ENDOTHELIAL MARKERS AND HOMOCYSTEINE IN PATIENTS WITH UNSTABLE ANGINA PECTORIS
A. Yildirir, L. Tokgozoglu, I. Haznedaroglu, I. Sinici, I. Unsal, G. Kabakci, K. Ovunc, S. Aksoyek, S. Kirazli, S. Kes, Ankara, Turkey
 09:30   ENDOTHELIAL DYSFUNCTION ALTERS CORONARY VASOMOTOR RESPONSE TO NON IONIC CONTRAST MEDIA
G. Musumeci, U. Limbruno, A.S. Petronio, R. Baglini, G. Paterni, A. Balbarini, M. Mariani, Pisa, Italy
 09:45 EFFECTS OF CIGARETTE SMOKING ON THE PLASMA LEVELS OF VCAM-1, IL-6, IL-2R, PROTEIN-C AND PROTEIN-S IN PATIENTS WITH CORONARY ARTERY DISEASE
Y. Cavusoglu, B. Gorenek, A. Unalýr, N. Ata, B. Timuralp, Eskisehir, Turkey
 10:00 CHRONIC ADMINSTRATION OF LOSARTAN AND HYDROCHILOROTHIAZIDE IMPROVES VASCULAR STATUS IN YOUNG CARDIOMYOPATHIC HAMSTERS
M.J. Crespo, W.C. De Mello, San Juan PR, USA
 10:15  CORRELATION BETWEEN SERUM LEVELS OF VON WILLEBRAND FACTOR AND FLOW MEDIATED DILATION OF THE BRACHIAL ARTERY IN PATIENTS WITH DIABETES MELLITUS
N. Prosmiti, B.A. Krokos, G. Ioannides, S. Koulouris, M. El Ali, D. Kardara, B. Kokkinou, N. Thalassinos, F. Kardaras, Athens, Greece
 10:30 CYTOKERATINS 8 AND 18 ARE EXPRESSED BY CORONARY ARTERY SMOOTH MUSCLE CELLS POST-ANGIOPLASTY
M.C. Moon, R. Singal, P. Molnar, L. Yau, D.F. Del Rizzo, P. Zahradka, Winnipeg MB, Canada
  C o f f e e B r e a k
S52:  DIAGNOSTIC METHODS
Chairpersons: J.S. Borer, New York NY, USA
M. Keltai, Budapest, Hungary
 08:30 NON-INVASIVE DETECTION OF CORONARY ARTERY BYPASS GRAFT PATENCY BY INTRAVENOUS ELECTRON-BEAM COMPUTED TOMOGRAPHIC CORONARY ANGIOGRAPHY
M. Ogata, S. Yamakami, J. Toyama, M. Okamoto, M. Tsuda, T. Matsushita, Y. Murakami, K. Iwata, T. Tani, T. Yamada, M. Kajiguchi, H. Satsurai, M. Yoshimoto, Ichinomiya Aichi, Japan
 08:45 IMMEDIATE BEDSIDE DIFFERENTIATION OF NORMAL VERSUS INFARCTED MYOCARDIUM WITH CONTRAST ECHOCARDIOGRAPHY EMPLOYING INTRAVENOUS PERFLENAPENT
S. Thanigaraj, H. Lee, S. Loslo, J.E. Perez, Saint Louis MO, USA
 09:00  EVALUATION OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION BY TISSUE DOPPLER IMAGING
A. Vitarelli, Y. Conde, R. Giubilei, P. Clemente, E. Giordani, E. Cimino, F. Fedele,
Rome, Italy
 09:15   ASSESSMENT OF PROXIMAL AND MIDDLE LEFT ANTERIOR DESCENDING CORONARY STENOSES IN HUMANS WITH MAGNETIC RESONANCE IMAGING
W.G. Hundley, C.A. Hamilton, D.M. Herrington, R.J. Applegate, G.A. Braden, M.S. Thomas, K.M. Link, Winston-Salem, NC, USA
 09:30 DETECTION OF VIABLE MYOCARDIUM BY DOBUTAMINE STRESS TAGGING MRI WITH 3D ANALYSIS BY AUTOMATIC TRACE METHOD IN CORONARY ARTERY DISEASE
S. Watanabe, I. Saitoh, T. Inoue, Y. Masuda, Chiba City, Japan
 09:45 ADDITIONAL CLINICAL VALUE OF GATED SPECT MYOCARDIAL PERFUSION IMAGING (Invited Lecture)
E.E. Van der Wall, Leiden, The Netherlands
 10:00 NEW PARADIGM OF USING PERIODIC TELEMETRY-MONITORED EXERCISE TESTS (PTMET) FOR ENHANCING CARDIAC PATIENT MANAGEMENT (Invited Lecture)
Y. Charuzi, C.M. Izumi, T.W. Lang, Los Angeles CA, USA
 10:15 SEVERITY OF CORONARY ARTERY CALCIFICATION BY ELECTRON BEAM COMPUTED TOMOGRAPHY PREDICTS SILENT MYOCARDIAL ISCHEMIA
Z-X. He, C.M. Pratt, M.S. Verani, J.J. Mahmarian, USA
 10:30 REPORT FROM THE FIRST INTERNATIONAL WORKSHOP ON CORONARY MR & CT ANGIOGRAPHY (Invited Lecture)
A.J. Duerinckx, D. Revel, P. Douek, Dallas TX, USA
  C o f f e e B r e a k
10:45 - 12:30  Hall A
PL05: NEW FRONTIERS IN INTERVENTIONAL CARDIOLOGY II: FOCUS ON VASCULAR BRACHYTHERAPY (VBT)
Chairperson: P.S. Teirstein, La Jolla CA, USA
10:45 INTRACORONARY BRACHYTHERAPY (Invited Lecture)
S. Silber, Munich, Germany
11:00 IN-STENT RESTENOSIS: NEW MANAGEMENT APPROACHES AND THE START TRIAL (Invited Lecture)
T.A. Bass, Jacksonville FL, USA
11:15  THE BETA-CATH BRACHYTHERAPY TRIAL (Invited Lecture)
M. Joyal, Montreal QC, Canada
11:30 INTRACORONARY BETA RADIATION THERAPY WITH 188RE-DTPA-FILLED BALLOON SYSTEM : SPARE ( SEOUL NATIONAL UNIVERSITY HOSPITAL POST-ANGIOPLASTY RHENIUM) TRIAL
S-I. Oh, S-H. Kim, I-H. Chae, B-H. Oh, M-M. Lee, Y.B. Park, Y-W. Lee, Seoul, South Korea
 
12:30   L u n c h B r e a k
 PL06:  ACUTE MYOCARDIAL INFARCTION
Chairpersons: S. Goldstein, Detroit MI, USA
E. Paolasso, Rosario, Argentina
 10:45 THROMBOLYSIS DOES NOT ALWAYS SAVE MYOCARDIUM (Invited Lecture)
M.S. Gotsman, Jerusalem, Israel
 11:00  PRE-HOSPITAL THROMBOLYSIS FOLLOWED BY IMMEDIATE PERCUTANEOUS CORONARY INTERVENTION AND STENT IN ACUTE MYOCARDIAL INFARCTION WHATEVER THE TIMI FLOW
C. Loubeyre, T. Lefevre, Y. Louvard, E. Obadia, K. Tazarourte, J.F. Piechaud, A. Margenet, P. Dumas, C. Pouges, M.C. Morice, Paris, France
 11:15 THROMBOLYSIS OR PRIMARY ANGIOPLASTY IN ACUTE MYOCARDIAL INFARCTION: A WRONG DILEMMA ? (Invited Lecture)
P. Touboul, Lyon, France
 11:30 METABOLIC MODULATION OF ACUTE MYOCARDIAL INFARCTION: A DIFFERENT APPROACH TO THE TREATMENT OF ACUTELY ISCHEMIC MYOCARDIUM (Invited Lecture)
R. Diaz, Rosario, Argentina
 11:45 GP IIb-IIIa ANTAGONISTS IN ACUTE CORONARY SYNDROMES WITH ST SEGMENT ELEVATION (Invited Lecture)
G. Montalescot, Paris, France
 12:00 GENETIC MARKERS OF LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION (Invited Lecture)
A. Rynkiewicz, Gdansk, Poland
 12:15  EARLY ABCIXIMAB ADMINISTRATION IN ACUTE MYOCARDIAL INFARCTION TREATED BY PRIMARY ANGIOPLASTY AND STENTING IN THE ADMIRAL STUDY
P. Ecollan, G. Montalescot, J.E. De La Coussaye, J. Vaque, P.E. Bollaert, P. Barragan, P. Pinton, Paris, France
 12:30  PREDICTORS OF CARDIOGENIC SHOCK AFTER ACUTE MYOCARDIAL INFARCTION
S.M. Macin, E.R. Perna, E.F. Farias, M.N. Augier, N.G. Rios, M.M. Civetta, J.R. Badaracco, Corrientes, Argentina
 12:45  L u n c h B r e a k
 S53:  ELECTROCARDIOLOGY AND ARRHYTHMIAS
Chairpersons: P. Touboul, Lyon, France
N.N. Kipshidze, Tbilisi, Georgia
 10:45 ANTIARRHYTHMIC EFFECT OF HEXASULFOBUTYLATED C60 DURING ACUTE PHASE OF CORONARY OCCLUSION IN ANESTHETIZED RATS
S-S. Huang, L-Y. Chiang, S-K. Tsai, L-M. Hung, M-C. Tsai, Taipei, Taiwan-R.O.C.
 11:00 CLINICAL SIGNIFICANCE OF INVERTED T WAVE DEEPENED TWICE IN PATIENT WITH ACUTE CORONARY SYNDROME
M. Fukumoto, J-D. Lee, H. Shimizu, T. Ueda, Fukui, Japan
 11:15 REPRODUCIBILITY AND INTEROBSERVER-CONCORDANCE OF SERIAL QT-DISPERSION MEASUREMENTS
T. Dieterle, E. Battegay, B. Martina, Basel, Switzerland
 11:30  ASSOCIATION OF QTc-DISPERSION WITH PROGNOSTIC MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE
R.B. Bestetti, P.F. Mata, V. Cardoso Jr., C. Guilherme, B. Fonseca, D. Santana, F. Folgosi, Sao Paulo, Brazil
11:45  ENTRAINMENT FOR LOCATING THE SOURCE OF DECREMENTAL CONDUCTION IN COMPUTER SIMULATION OF REENTRY CIRCUITS
T. Ota, T. Iwa, Y. Wakida, M. Fukuta, M. Yonezu, Y. Suzuki, W.G. Stevenson,
Nagakute, Japan
12:00  META ANALYSIS OF NEW ECG SIGN FOR RIGHT VENTRICULAR ACUTE MYOCARDIAL INFARCTION
G. Koracevic, Nis, Yugoslavia
12:15  MORE ABOUT THE ELECTROCARDIOGRAM OF ACUTE MYOCARDIAL INFARCTION (Invited Lecture)
O.H. Kracoff, A. Caspi, Rehovot, Israel
12:30   PREVENTION OF VASOVAGAL SYNCOPE AFTER CORONARY INTERVENTIONS: A RANDOMIZED STUDY
S. Mishra, D. Gupta, R. Narang, R. Arora, V.K. Bahl, R. Ghodeshwar, S.C. Manchanda, New Delhi, India
 12:45  L u n c h B r e a k
 14:00 - 17:30 Hall A
 SA01:  Satellite Symposium
  CLINICAL AND PRACTICAL CONSIDERATIONS FOR THE USE OF GAMMA RADIATION WITH IR-192 FOR THE TREATMENT OF IN-STENT RESTENOSIS
Sponsored by an unrestricted educational grant from
Cordis Johnson & Johnson
  CLINICAL ASPECTS RELATED TO THE USE OF GAMMA THERAPY IN THE TREATMENT OF INSTENT-RESTENOSIS: ANALYSIS OF CLINICAL DATA AND TECHNIQUES
P.S. Teirstein, USA
RADIOONCOLOGICAL CONSIDERATIONS DURING INTRA BRACHYTHERAPY: THE ROLE OF THE ONCOLOGIST AND THE PATIENT RISK
P.C. Levendag, The Netherlands
PHYSICS OF GAMMA RADIATION QUALITY ASSURANCE: CALIBRATION. DOSE MEASUREMENT SHIELDING, REGULATIONS
W. Dries, The Netherlands
COST EFFICACY WITH GAMMA RADIATION
R.J. Laham, Boston MA, USA
 15:35  C o f f e e B r e a k
 SA02:  Satellite Symposium

PREVENTION OF CORONARY ARTERY DISEASE: TOWARDS EVIDENCE BASED MEDICINE VIA OUTCOME TRIALS

Sponsored by an unrestricted educational grant from Bayer AG
Chairpersons: J. Patsch, Innsbruck, Austria
J.-M. Lablanche, Lille, France

 14:00 INTRODUCTION
J.R. Patsch, Innsbruck, Austria
 14:05 HYPERTENSION AND DYSLIPIDAEMIA AS RISK FACTORS FOR CAD
B. Neal, Sydney, Australia
 14:35 RESTORATION OF ENDOTHELIAL FUNCTION - THE ENCORE TRIAL
G. Noll, Zurich, Switzerland
 15:05 STATINS IN ACUTE MYOCARDIAL INFARCTION
J.-M. Lablanche, Lille, France
 15:35 INSIGHTS FROM THE INTERNATIONAL NIFEDIPINE TRIAL IN HYPERTENSION
L. Ruilope, Madrid, Spain
 16:05 CLOSING REMARKS
J.-M. Lablanche, Lille, France
14:00 - 15:30 Hall C
S54:  RISK FACTORS AND PROGNOSIS
Chairpersons: A. Evans, Belfast, UK
S.C. Smith, Chapel Hill NC, USA
 14:00 BENEFICIAL EFFECT OF HMG-COA REDUCTASE INHIBITORS ON LONG-TERM PROGNOSIS IN PATIENTS WITH HEALED MYOCARDIAL INFARCTION
H. Furuta, A. Kimrua, N. Takeda, T. Watanabe, H. Ino, T. Taniwa, H. Yabushita, Osaka, Japan
 14:15 RISK STRATIFICATION ONE YEAR AFTER SUCCESSFUL CORONARY REVASCULARIZATION, THE LACK OF A ROLE FOR ROUTINE EXERCISE TESTING
R.J. Krone, R.M. Hardison, B.R. Chaitman, R.J. Gibbons, G. Sopko, R. Bach, K.M. Detre, St. Louis MO, USA
 14:30 LONG TERM PROGNOSTIC SIGNIFICANCE OF SILENT VERSUS SYMPTOMATIC ISCHEMIA ON EXERCISE TESTING PERFORMED 3 WEEKS AFTER ACUTE MYOCARDIAL INFARCTION
L.A. Abboud, J. Hir, I. Eisen, W. Markiewicz, Haifa, Israel
 14:45 INSULIN RESISTANCE IS A SIGNIFICANT CORONARY RISK FACTOR: STUDIES IN ORGANIC AND VASOSPASTIC CORONARY ARTERY DISEASE
Y. Nishimura, N. Kotooka, A. Hashimoto, T. Yoshimura, T. Morooka, K. Yoshida, S. Tsuji, T. Tokushima, A. Hisatomi, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan
 15:00 ISCHAEMIC HEART DISEASE MANAGEMENT: THE INFLUENCE OF SOCIOECONOMIC STATUS. (IS THE 'PRIVATE' PATIENT BETTER OFF?)
P.A. Sullivan, O. Mc Cabe, P. Nash, Mallow, Ireland
 15:15 CLINICAL SIGNIFICANCE OF EXERCISE INDUCED T WAVE NORMALIZATION IN PATIENTS WITH Q-WAVE MYOCARDIAL INFARCTION : COMPARISON WITH MYOCARDIAL PERFUSION SCINTIGRAPHY
C. Ermeydan, B. Mutlu, O. Demirkol, Y. Basaran, Istanbul, Turkey
  C o f f e e B r e a k
17:30 - 18:40
 SA04: Highlight Session
WHAT IS THE ROLE OF MODERATE ALCOHOL CONSUMPTION IN THE PREVENTION OF CORONARY ARTERY DISEASE?

Sponsored by:
The Institute on Lifestyle & Health, Boston University School of Medicine with an unrestricted educational grant from the Research & Education Committee of Wine Institute, San Francisco CA, USA

 17:30 INTRODUCTION TO SEMINAR
R.C. Ellison, Boston MA, USA
 17:35 DO WINE AND OTHER ALCOHOLIC BEVERAGES REDUCE THE RISK OF CORONARY DISEASE? THE EPIDEMIOLOGIC EVIDENCE
A.L. Klatsky, Oakland CA, USA
 17:50 MECHANISMS OF PROTECTION AGAINST CORONARY DISEASE FOR WINE AND ALCOHOL
J.A. Vita, Boston MA, USA
 18:05 SHOULD PHYSICIANS PRESCRIBE ALCOHOL TO PREVENT CORONARY ARTERY DISEASE?
R.C. Ellison, Boston MA, USA
 18:40 QUESTIONS AND DISCUSSION
PANELISTS
 18:45 Wine tasting

 


This site was developed by .